United States· US:74527-022_97ee3be5-cd7f-45d4-85c7-b48ad596e837

MARGENZA

A margetuximab product containing margetuximab, registered in United States by MacroGenics, Inc.

ATC L01FD06US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMARGENZAATCL01FD06REGISTER NO.US:74527-022_97ee3be5…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
MARGETUXIMAB
Manufacturer
MacroGenics, Inc
Country
United States (US)
ATC code
L01FD06
ATC class
Margetuximab
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    7452702202
    1 VIAL, SINGLE-DOSE in 1 CARTON (74527-022-02) / 10 mL in 1 VIAL, SINGLE-DOSE (74527-022-01)
  • ndc11
    7452702203
    4 VIAL, SINGLE-DOSE in 1 CARTON (74527-022-03) / 10 mL in 1 VIAL, SINGLE-DOSE (74527-022-01)
  • ndc11
    74527-022-02
  • ndc11
    74527-022-03

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under L01FD06

Margetuximab, as other registers publish it.

All margetuximab products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5804f923-7c2a-4e8b-8982-43c23fbfbefb
GET /v1/drugs/5804f923-7c2a-4e8b-8982-43c23fbfbefb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "25",
  "substance": "MARGETUXIMAB",
  "productndc": "74527-022",
  "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "BLA761150",
  "marketing_category": "BLA"
}

See everything about margetuximab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.